Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Melanoma 7 Neoplasms 5 Head and Neck Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Carcinoma, Merkel Cell 3 Squamous Cell Carcinoma of Head and Neck 2 Kidney Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Uterine Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Recurrence 1 Penile Neoplasms 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1

Interventions

Cisplatin 6 pembrolizumab 5 fludarabine 5 Nivolumab 5 Cyclophosphamide 5 aldesleukin 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Radiotherapy 3 Ipilimumab 3 fludarabine phosphate 2 entinostat 2 cabozantinib 2 avelumab 2 aflibercept 2 Specimen Handling 2 CTLA-4 Antigen 2 Biopsy 2 Adoptive Transfer 2 vinflunine 1 toripalimab 1 rocakinogene sifuplasmid 1 ripretinib 1 oncogene protein E7, Human papillomavirus type 16 1 niraparib 1 nimotuzumab 1 lenvatinib 1 enfortumab vedotin 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Penile Neoplasms × cemiplimab × Genitourinary × Clear all

NCT07101822 2025-08-03

BRAVA PENILE

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡